Search Results 931-940 of 17557 for treatment resistant depression
PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study To ...
A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell ...
... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...
... drug-resistant epilepsy patients using CorTec's Brain Interchange Evaluation ... A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called ...
We hypothesize that machine learning can be leveraged to uncover distinct genetic vulnerabilities that underlie treatment response and resistance for patients ...
... therapy of TILT-123 and pembrolizumab in patients with platinum resistant or refractory ovarian cancer. A Study Of Intratumoral Injection Of Autologous ...
A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma · Share ...
Natural remedies for depression: Are they effective? Nearsightedness ... Treatment of parathyroid disease at Mayo Clinic · Treatment-resistant depression ...
Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non- ...
Mayo Clinic discovery of breast cancer treatment resistance can lead to new hope for some. ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!